Patents by Inventor Joseph Elder

Joseph Elder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR PROVIDING SUPPLEMENTAL INFORMATION WITH A RESPONSE TO A COMMAND
    Publication number: 20240152319
    Abstract: Systems and methods for providing supplemental information with a response to a command are provided herein. In some embodiments, audio data representing a spoken command may be received by a cloud-based information system. A response to the command may be retrieved from a category related to the context of the command. A supplemental information database may also be provided that is pre-populated with supplemental information related to an individual having a registered account on the cloud-based information system. In response to retrieving the response to the command, supplemental information may be selected from the supplemental information database to be appended to the response to the command. A message may then be generated including the response and the supplemental information appended thereto, which in turn may be converted into audio data representing the message, which may be sent to a voice-controlled electronic device of the individual.
    Type: Application
    Filed: October 16, 2023
    Publication date: May 9, 2024
    Inventors: Srikanth Doss Kadarundalagi Raghuram Doss, Jeffery David Wells, Richard Dault, Benjamin Joseph Tobin, Mark Douglas Elders, Stanislava R. Vlasseva, Skeets Jonathan Norquist, Nathan Lee Bosen, Ryan Christopher Rapp
  • Catalyst composition and system having extended lifetime
    Patent number: 11945896
    Abstract: A Ziegler-Natta catalyst composition is disclosed. The catalyst composition includes an internal electron donor with improved polymerization kinetics, a long lifetime, improved stereoselectivity and/or improved hydrogen response.
    Type: Grant
    Filed: September 10, 2020
    Date of Patent: April 2, 2024
    Assignee: W.R. Grace & Co.-CONN.
    Inventors: Joseph Coalter, III, Rose Kent, Adam Marwitz, Ronald Epstein, Michael Elder
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
    Publication number: 20220370403
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: February 10, 2022
    Publication date: November 24, 2022
    Applicant: Humanetics Corporation
    Inventors: Edmund Joseph Elder, JR., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
    Publication number: 20210000788
    Abstract: The present invention is directed to formulations of genistein and methods for making and using, the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: July 21, 2020
    Publication date: January 7, 2021
    Applicant: Humanetics Corporation
    Inventors: Edmund Joseph Elder, JR., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • Nanoparticle isoflavone compositions and methods of making and using the same
    Patent number: 10729674
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: August 4, 2020
    Assignee: Humanetics Corporation
    Inventors: Edmund Joseph Elder, Jr., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20190160038
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: July 3, 2018
    Publication date: May 30, 2019
    Applicant: Humanetics Corporation
    Inventors: Edmund Joseph Elder, JR., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • Nanoparticle isoflavone compositions and methods of making and using the same
    Patent number: 10039739
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: August 7, 2018
    Assignee: Humanetics Corporation
    Inventors: Edmund Joseph Elder, Jr., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20170304258
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: July 6, 2017
    Publication date: October 26, 2017
    Applicant: Humanetics Corporation
    Inventors: Edmund Joseph Elder, JR., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • Nanoparticle isoflavone compositions and methods of making and using the same
    Patent number: 9724325
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Grant
    Filed: September 7, 2016
    Date of Patent: August 8, 2017
    Assignee: Humanetics Corporation
    Inventors: Edmund Joseph Elder, Jr., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • Nanoparticle isoflavone compositions and methods of making and using the same
    Patent number: 9636322
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Grant
    Filed: March 1, 2016
    Date of Patent: May 2, 2017
    Assignee: Humanetics Corporation
    Inventors: Edmund Joseph Elder, Jr., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20160374984
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: September 7, 2016
    Publication date: December 29, 2016
    Applicant: Humanetics Corporation
    Inventors: Edmund Joseph Elder, JR., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20160175276
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: March 1, 2016
    Publication date: June 23, 2016
    Applicant: Humanetics Corporation
    Inventors: Edmund Joseph Elder, JR., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • Nanoparticle isoflavone compositions and methods of making and using the same
    Patent number: 9308167
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Grant
    Filed: October 27, 2014
    Date of Patent: April 12, 2016
    Assignee: Humanetics Corporation
    Inventors: Edmund Joseph Elder, Jr., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20150050357
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: October 27, 2014
    Publication date: February 19, 2015
    Applicant: Humanetics Corporation
    Inventors: Edmund Joseph Elder, JR., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • Nanoparticle isoflavone compositions and methods of making and using the same
    Patent number: 8900635
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Grant
    Filed: November 15, 2010
    Date of Patent: December 2, 2014
    Assignee: Humanetics Corporation
    Inventors: Edmund Joseph Elder, Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • Nanoparticle isoflavone compositions and methods of making and using the same
    Patent number: 8551530
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: October 8, 2013
    Assignee: Humanetics Corporation
    Inventors: Edmund Joseph Elder, Jr., Mark Joseph Sacchetti, Randall Joseph Tiachac, John L. Zenk
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20120164190
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: March 2, 2012
    Publication date: June 28, 2012
    Applicant: Humanetics Corporation
    Inventors: Edmund Joseph Elder, Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20120121654
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: November 15, 2010
    Publication date: May 17, 2012
    Applicant: HUMANETICS CORPORATION
    Inventors: Edmund Joseph Elder, JR., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • Salts and polymorphs of a VEGF-R inhibitor
    Patent number: 7928226
    Abstract: The invention relates to salts and free base forms of N,2-dimethyl-6-[7-(2-morpholinoethoxy)quinolin-4-yloxy]benzofuran-3-carboxamide. The invention further relates to pharmaceutical compositions of these salts and free base forms and methods of treating disorders such as cancer using such compositions.
    Type: Grant
    Filed: July 27, 2006
    Date of Patent: April 19, 2011
    Assignee: Agouron Pharmaceuticals Inc.
    Inventors: Yi Li, Jia Liu, Anand Sistla, Bruce Joseph Elder, Yufeng Hong, Paul Kenneth Isbester, Grant Jackson Palmer, Jonathon Stuart Salsbury, Luckner Gerard Ulysse
  • SALTS AND POLYMORPHS OF A VEGF-R INHIBITOR
    Publication number: 20090048254
    Abstract: The invention relates to salts and free base forms of N,2-dimethyl-6-[7-(2-morpholinoethoxy)quinolin-4-yloxy]benzofuran-3-carboxamide. The invention further relates to pharmaceutical compositions of these salts and free base forms and methods of treating disorders such as cancer using such compositions.
    Type: Application
    Filed: July 27, 2006
    Publication date: February 19, 2009
    Applicant: PFIZER INC.
    Inventors: Yi Li, Jia Liu, Anand Sistla, Bruce Joseph Elder, Yufeng Hong, Paul Kenneth Isbester, Grant Jackson Palmer, Jonathon Stuart Salsbury, Luckner Gerard Ulysse